SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Portola Pharmaceuticals, Inc. and Lee Pharmaceuticals Enter Into Agreement to Expand Phase 3 APEX Study of Betrixaban Into China